Skip to content

Metastatic metaplastic triple negative breast cancer response to sacituzumab govitecan and biomarker targetability

Sep 2026 · Breast Cancer Research and Treatment · Vol 219 · 0 citations · 22 references
Medicine
View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.